These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39197297)

  • 1. Factors associated with the long-term use of benzodiazepine receptor agonists as hypnotics among patients with major depressive disorder and comorbid insomnia.
    Habukawa M; Kakuma T; Ozone M; Uchimura N
    J Psychiatr Res; 2024 Oct; 178():359-366. PubMed ID: 39197297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of hypnotic prescribing for residual insomnia and recurrence of major depressive disorder: a retrospective cohort study using a Japanese health insurance claims database.
    Yamato K; Inada K; Enomoto M; Marumoto T; Takeshima M; Mishima K
    BMC Psychiatry; 2021 Jan; 21(1):40. PubMed ID: 33441086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database.
    Okuda S; Qureshi ZP; Yanagida Y; Ito C; Homma Y; Tokita S
    BMC Psychiatry; 2023 Apr; 23(1):278. PubMed ID: 37081408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and associated factors of hypnotics dependence among Japanese outpatients with psychiatric disorders.
    Murakoshi A; Takaesu Y; Komada Y; Ishikawa J; Inoue Y
    Psychiatry Res; 2015 Dec; 230(3):958-63. PubMed ID: 26614012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dosage of hypnotics predicts subsequent sleep-related breathing disorders and is associated with worse outcomes for depression.
    Li CT; Bai YM; Lee YC; Mao WC; Chen MH; Tu PC; Chen YS; Chen TJ; Chang WH; Su TP
    Sleep; 2014 Apr; 37(4):803-9, 809A-809B. PubMed ID: 24688165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.
    Krystal A; Fava M; Rubens R; Wessel T; Caron J; Wilson P; Roth T; McCall WV
    J Clin Sleep Med; 2007 Feb; 3(1):48-55. PubMed ID: 17557453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription Patterns and Predisposing Factors of Benzodiazepine and Z-Hypnotic Use During Pregnancy: A Nationwide Cohort Study.
    Meng LC; Lin CW; Chuang HM; Chen YY; Shang CY; Wu CY; Chen LK; Hsiao FY
    Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5847. PubMed ID: 38898542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A psychiatric perspective on insomnia.
    McCall WV
    J Clin Psychiatry; 2001; 62 Suppl 10():27-32. PubMed ID: 11388587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current state of hypnotic use disorders: Results of a survey using the Japanese version of Benzodiazepine Dependence Self-Report Questionnaire.
    Yamamoto M; Inada K; Enomoto M; Habukawa M; Hirose T; Inoue Y; Ishigooka J; Kamei Y; Kitajima T; Miyamoto M; Shinno H; Nishimura K; Ozone M; Takeshima M; Suzuki M; Yamashita H; Mishima K
    Neuropsychopharmacol Rep; 2021 Mar; 41(1):14-25. PubMed ID: 33259705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in prescriptions for sedative-hypnotics among Korean adults: a nationwide prescription database study for 2011-2015.
    Lee MH; Choi JW; Lee J; Shin A; Oh SM; Jung SJ; Lee YJ
    Soc Psychiatry Psychiatr Epidemiol; 2019 Apr; 54(4):477-484. PubMed ID: 30406284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepine, Z-drug, and sleep medication prescriptions in male and female people with opioid use disorder on buprenorphine and comorbid insomnia: an analysis of multistate insurance claims.
    Martin CE; Patel H; Dzierewski JM; Moeller FG; Bierut LJ; Grucza RA; Xu KY
    Sleep; 2023 Jun; 46(6):. PubMed ID: 36970994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypnotic Discontinuation in Chronic Insomnia.
    Hintze JP; Edinger JD
    Sleep Med Clin; 2022 Sep; 17(3):523-530. PubMed ID: 36150811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Use of Z-Hypnotics and Co-medication with Benzodiazepines and Opioids.
    Sakshaug S; Handal M; Hjellvik V; Berg C; Ripel Å; Gustavsen I; Mørland J; Skurtveit S
    Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):292-298. PubMed ID: 27717229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Main neuroendocrine features and therapy in primary sleep troubles.
    Amihăesei IC; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):862-6. PubMed ID: 23272543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with hypnotics polypharmacy in the Japanese population.
    Shimura A; Takaesu Y; Sugiura K; Takagi S; Okawa Y; Inoue Y
    Sleep Med; 2024 Oct; 122():99-105. PubMed ID: 39141977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of benzodiazepine use in individuals with insomnia.
    Morin CM; Bélanger L; Bernier F
    Sleep Med; 2004 Sep; 5(5):457-62. PubMed ID: 15341890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the sleep impact scale in patients with major depressive disorder and insomnia.
    Lasch K; Joish VN; Zhu Y; Rosa K; Qiu C; Crawford B
    Curr Med Res Opin; 2009 Jul; 25(7):1699-710. PubMed ID: 19505198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric comorbidities and prescribing tendencies of sleep medications and related medications in young people with insomnia: a United States commercial claims-based analysis.
    Bushnell G; Ivanenko A; Horton DB; Lunsford-Avery JR; Posner J; Gerhard T; Suarez E; Olfson M
    Sleep; 2024 May; 47(5):. PubMed ID: 38430553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.
    Chakos M; Patel JK; Rosenheck R; Glick ID; Hammer MB; Tapp A; Miller A; Miller D
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):124-34. PubMed ID: 21983496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.